Photo: For Mr Trieger, the experimental treatment was a risk worth taking. (Supplied: Elizabeth Bawden) When 33-year-old cystic fibrosis patient Jordan Trieger received a double-lung transplant, it was meant to be a second chance at life. Researcher Dr Tim Wells has been pioneering a new treatment for drug-resistant bacterial infections The technique ‘washes’ the blood of all antibodies and replaces them with healthy ones Mr Trieger’s successful case will now be published in international medical journals But like 40 per cent of patients who undergo a transplant, Mr Trieger developed a bacterial infection and his body started rejecting his new organ. What made his case even more difficult to treat was the fact his body was not responding to traditional treatment options like antibiotics or further surgery. "We didn’t really know what to do — I wasn’t getting better [despite them] giving me several different kinds of different antibiotics," […]